<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35469217</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1748-6718</ISSN><JournalIssue CitedMedium="Internet"><Volume>2022</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Computational and mathematical methods in medicine</Title><ISOAbbreviation>Comput Math Methods Med</ISOAbbreviation></Journal><ArticleTitle>Amyotrophic Lateral Sclerosis Symptom Score in Integrative Treatments (ALS-SSIT) for Evaluating Therapeutic Effect of Traditional Chinese Medicine: A Prospective Study.</ArticleTitle><Pagination><StartPage>7594481</StartPage><MedlinePgn>7594481</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">7594481</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2022/7594481</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To evaluate the reliability, validity, sensitivity, and clinical applicability of a new scale-the amyotrophic lateral sclerosis symptom score in integrative treatments (ALS-SSIT)-for measuring the effect of traditional Chinese medicine (TCM) in patients with amyotrophic lateral sclerosis (ALS).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A total of 160 patients with ALS were enrolled and followed up for 6 months. All patients received TCM. Patients were evaluated at enrollment and at the end of 6 months with a new scale, the ALS-SSIT, developed after extensive consultations with TCM experts with several years of experience in the treatment of ALS. The 36-item Medical Outcomes Study Short Form (SF-36) scale and the amyotrophic lateral sclerosis functional rating scale (ALSFRS) were used as the reference standards.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The acceptance rate and completion rate of the ALS-SSIT scale were high, and the content validity was confirmed by experts. Test-retest performed at enrollment and at 6 months showed good reliability of the ALS-SSIT scale (Cronbach <i>&#x3b1;</i>, 0.9172 and 0.9181, respectively). The ALS-SSIT scale score showed significant change at 6 months, indicating the ability to reflect the change in disease severity.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The ALS-SSIT appears to be a feasible, reliable, and sensitive tool for the evaluation of the effect of TCM in patients with ALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Xuanlu Zheng et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Xuanlu</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-2431-849X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schr&#xf6;der</LastName><ForeName>Joana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HanseMerkur Center for Traditional Chinese Medicine at the Universtiy Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sima</LastName><ForeName>Dandan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Mingzhe</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qiudong</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0003-2162-2071</Identifier><AffiliationInfo><Affiliation>Department of Integrative Neurology, Pudong Traditional Chinese Medicine Hospital, Shanghai 201205, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Weidong</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-0380-4210</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Math Methods Med</MedlineTA><NlmUniqueID>101277751</NlmUniqueID><ISSNLinking>1748-670X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008516" MajorTopicYN="N">Medicine, Chinese Traditional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that there are no conflicts of interest with regard to the publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>26</Day><Hour>5</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35469217</ArticleId><ArticleId IdType="pmc">PMC9034932</ArticleId><ArticleId IdType="doi">10.1155/2022/7594481</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pan W., Su X., Bao J., et al. Strengthen the spleen reinforcing qi method in treatment of amyotrophic lateral sclerosis: an open randomized controlled trial. Academic Journal of Shanghai University of Traditional Chinese Medicine . 2013;27(3):38&#x2013;41. doi: 10.16306/j.1008-861x.2013.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.16306/j.1008-861x.2013.03.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Sima D., Schoder J., Zheng X., Wang M., Pan W. Effects of Wenshen Jianpi recipe hot compress in the treatment of amyotrophic lateral sclerosis: a randomized controlled clinical trial. Academic Journal of Shanghai University of Traditional Chinese Medicine . 2021;35(4):25&#x2013;28. doi: 10.16306/j.1008-861x.2021.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.16306/j.1008-861x.2021.04.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W., Su X., Bao J., et al. Open randomized clinical trial on JWSJZ decoction for the treatment of ALS patients. Evidence-based Complementary and Alternative Medicine . 2013;2013:5. doi: 10.1155/2013/347525.347525</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/347525</ArticleId><ArticleId IdType="pmc">PMC3777196</ArticleId><ArticleId IdType="pubmed">24093046</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W. Neurology . Beijing: People's Medical Publishing House; 2008.</Citation></Reference><Reference><Citation>McHorney C. A., Ware J. E. J., Raczek A. E. The MOS 36-item short-form health survey SF-36. Medical Care . 1993;31(3):247&#x2013;263. doi: 10.1097/00005650-199303000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199303000-00006</ArticleId><ArticleId IdType="pubmed">8450681</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum J. M., Stambler N., Malta E., et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. Journal of the Neurological Sciences . 1999;169(1-2):13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao W., Jiang W., Gao P., Yuan Y., Li G., Pan W. &#x200a;Treatment amyotrophic lateral sclerosis from spleen based on the basic theory of Traditional Chinese Medicine. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease . 2019;17(7):1029&#x2013;1031. doi: 10.12102/i.sn.1672-1349.2019.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.12102/i.sn.1672-1349.2019.07.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W. Differentiation and treatment of neurodegenerative diseases based on the theory of strengthening the spleen, soothing the liver, replenishing the liver and kidney of Traditional Chinese Medicine. Academic Journal of Shanghai University of Traditional Chinese Medicine . 2019;33(2):1&#x2013;6. doi: 10.16306/j.1008-861x.2019.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.16306/j.1008-861x.2019.02.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W., Chen X., Bao J., et al. The use of integrative therapies in patients with amyotrophic lateral sclerosis in Shanghai, China. Evidence-based Complementary and Alternative Medicine . 2013;2013:6. doi: 10.1155/2013/613596.613596</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/613596</ArticleId><ArticleId IdType="pmc">PMC3865630</ArticleId><ArticleId IdType="pubmed">24363770</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W. Modern medicine should focus on the symptoms of patients and carry out comprehensive treatment with integrative medicine. Journal of Neurology and Neurorehabilitation . 2019;15(1):9&#x2013;14. doi: 10.12022/jnnr.2021-0035.</Citation><ArticleIdList><ArticleId IdType="doi">10.12022/jnnr.2021-0035</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Ren L., Bai Z., Huo S., Gu Z. Development of the evaluation scale for cardiovascular neurosis with liver-depression and spleen-deficiency and evaluation of reliability, validity and sensitivity. Chinese Archives of Traditional Chinese Medicine . 2016;34(9):2107&#x2013;2109. doi: 10.13193/j.issn.1673-7717.2016.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.13193/j.issn.1673-7717.2016.09.017</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>